{
  "id": "pranax-lands-17m-to-harness-exosomes-in-regenerative-biologics",
  "title": "PranaX lands $17m to harness exosomes in regenerative biologics",
  "summary": "Company initially targets ‘exosome-based wellness’ after licensing new technologies developed at the University of Texas. US biotech PranaX Corp has secured an oversubscribed $17 million Series A financing round as it seeks to ramp up its development and commercialization of exosome-based regenerative biologics. The Houston-based company says it is developing “biologically informed” approaches aimed at […] The post PranaX lands $17m to harness exosomes in regenerative biologics appeared first on Longevity.Technology.",
  "url": "https://longevity.technology/news/pranax-lands-17m-to-harness-exosomes-in-regenerative-biologics/",
  "source": "Longevity.Technology",
  "author": "Danny Sullivan",
  "category": "news",
  "publishedAt": "2026-02-02T15:26:53.000Z",
  "fetchedAt": "2026-02-04T10:49:05.816Z",
  "relevanceScore": 0.2,
  "matchedKeywords": [
    "longevity"
  ],
  "relatedProducts": [],
  "type": "web",
  "savedAt": "2026-02-04T10:49:05.888Z"
}